SCHEMBL5201373

SCHEMBL5201373

CS(=O)(=O)Nc1cccc(CC#N)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KEAP1 Q14145 1/20 0.47
▸ POLB P06746 1/20 0.45
▸ DRD2 P14416 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ PARP1 P09874 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ ENPP2 Q13822 1/20 0.42
▸ KIF11 P52732 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9781898 0.85 NR3C1 (0.52) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL10405236 0.84 NR3C1 (0.51) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL8275435 0.80 NR3C1 (0.54) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL7902370 0.80 PTGS1 (0.59) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL5262193 0.80 NR3C1 (0.56) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL4625352 0.80 SMN1; SMN2 (0.63) ALDH1A1SMN1; SMN2KEAP1KDM4ELMNA
SCHEMBL3560306 0.78 IKBKB (0.58) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL14345545 0.78 NR3C1 (0.55) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL2284909 0.78 HTR6 (0.64) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB
SCHEMBL29203533 0.78 NR3C1 (0.59) NR3C1ALDH1A1SMN1; SMN2KEAP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021143923-A1 BORONIC ACID DERIVATIVES 首药控股(北京)股份有限公司 2021-07-22 — — WO disclosed
CN-106170290-A Substituted di-amino-pyrimidine based compound, combinations thereof and treatment method thereof 西格诺药品有限公司 2016-11-30 — — CN disclosed
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 — — EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 — — US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 — — US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 — — EP disclosed
Send feedback